|
|
Volumn 16, Issue 6, 2010, Pages 611-
|
|
In vision trial, some researchers would rather see double
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEVACIZUMAB;
RANIBIZUMAB;
DRUG COST;
DRUG INDUSTRY;
EYE EXAMINATION;
FUNDING;
GOVERNMENT;
HUMAN;
LOW LEVEL LASER THERAPY;
MEDICAL RESEARCH;
NOTE;
PRIORITY JOURNAL;
RETINA MACULA AGE RELATED DEGENERATION;
RETINA MACULA EDEMA;
ANTIBODIES, MONOCLONAL;
CLINICAL TRIALS AS TOPIC;
COSTS AND COST ANALYSIS;
DIABETIC RETINOPATHY;
HUMANS;
MACULAR EDEMA;
PUBLIC-PRIVATE SECTOR PARTNERSHIPS;
UNITED STATES;
|
|
EID: 77953179877
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm0610-611 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|
